Characterizing Drug-Induced Stuttering: Implications for Speech Fluency Assessment and Treatment

The language used in the description reflects the language of the session.

Authors:

Alyssa Stowe, Department of Speech Language Pathology, University of Toronto; Ala Refai, Department of Speech Language Pathology, University of Toronto; Luc De Nil, Department of Speech Language Pathology, University of Toronto.

Literature in drug-induced stuttering is mostly composed of case reports that focus on medical and pharmacological effects. Typically, very little consideration is given to factors that may affect the type of fluency treatment that should be recommended or to the psychosocial impact of acquired stuttering on the client. In this poster, we will review the literature on drug-induced stuttering and use the biopsychosocial framework to discuss additional factors that should be considered to guide treatments and improve client outcomes.